231 related articles for article (PubMed ID: 17900231)
21. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
[TBL] [Abstract][Full Text] [Related]
22. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
Ouhadj O; Chergui I; Mendil L; Nouri MT
J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
[TBL] [Abstract][Full Text] [Related]
23. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1601-9. PubMed ID: 20524132
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
[TBL] [Abstract][Full Text] [Related]
25. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
26. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
27. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.
Wittström E; Holmberg H; Hvarfner C; Andréasson S
Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
Hasanreisoglu M; Weinberger D; Mimouni K; Luski M; Bourla D; Kramer M; Robinson A; Axer-Siegel R
Eur J Ophthalmol; 2009; 19(4):607-12. PubMed ID: 19551676
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal bevacizumab for neovascular glaucoma.
Vasudev D; Blair MP; Galasso J; Kapur R; Vajaranant T
J Ocul Pharmacol Ther; 2009 Oct; 25(5):453-8. PubMed ID: 19857107
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab in a patient with neovascular glaucoma.
Kahook MY; Schuman JS; Noecker RJ
Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab for neovascular glaucoma.
Andrijević-Derk B; Vatavuk Z; Bencić G; Novak-Laus K; Mandić Z
Acta Clin Croat; 2008 Sep; 47(3):175-9. PubMed ID: 19175068
[TBL] [Abstract][Full Text] [Related]
33. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.
Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K
Acta Ophthalmol; 2010 Feb; 88(1):96-102. PubMed ID: 19775309
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up.
Costagliola C; Cipollone U; Rinaldi M; della Corte M; Semeraro F; Romano MR
Br J Clin Pharmacol; 2008 Nov; 66(5):667-73. PubMed ID: 19032174
[TBL] [Abstract][Full Text] [Related]
36. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
Fong AW; Lee GA; O'Rourke P; Thomas R
Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma.
Yeung SN; Paton KE; Waite C; Maberley DA
Can J Ophthalmol; 2010 Jun; 45(3):269-73. PubMed ID: 20379286
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
Vatavuk Z; Bencic G; Mandic Z
Eur J Ophthalmol; 2007; 17(2):269-71. PubMed ID: 17415704
[TBL] [Abstract][Full Text] [Related]
39. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.
Ghosh S; Singh D; Ruddle JB; Shiu M; Coote MA; Crowston JG
Clin Exp Ophthalmol; 2010 May; 38(4):353-7. PubMed ID: 20665941
[TBL] [Abstract][Full Text] [Related]
40. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]